U.S. Pharmacy SKU & Inventory Guide
A specification-led guide for pharmacies, healthcare distributors and procurement teams building an accurate insulin syringe assortment, approving substitutes and preparing comparable wholesale RFQs.
Scope: This is an institutional purchasing resource, not patient-specific dosing or product-selection advice. Match the insulin concentration, syringe scale and exact configuration to current drug labeling, prescriptions, approved organizational policy and qualified professional directions. Public catalogs show available configurations; they do not establish national pharmacy sales rankings.
Quick answer
What Insulin Syringe Specifications Are Commonly Listed for U.S. Pharmacies?
The recurring U.S.-market capacity categories are 0.3 mL, 0.5 mL and 1 mL, while current manufacturer and distributor portfolios repeatedly list 29G, 30G and 31G fixed-needle configurations with short and traditional-length needles. Representative combinations include 31G × 6 mm, 31G × 8 mm and 29G or 30G × approximately 12–12.7 mm. These are catalog patterns, not a national sales ranking and not proof that every combination is offered in every capacity.
A pharmacy should never approve an item from “0.5 mL” or “31G 8mm” alone. The complete SKU must also fix the concentration scale, maximum unit marking, graduation interval, fixed-needle or safety design, exact manufacturer REF, sterile presentation, quantity per box, boxes per case, identifiers, lot and expiration format, label revision and substitution status.
Executive summary
Key Takeaways for Pharmacy Buyers
- Use “commonly listed configurations,” not “national best sellers,” unless proprietary sales data supports a ranking.
- Separate capacity, concentration scale and graduation. A 0.3 mL syringe is not automatically a half-unit syringe, and a 1 mL syringe should not be assigned a graduation without REF-level proof.
- Higher gauge numbers generally indicate a smaller outside needle diameter, but gauge does not identify length, scale or suitability.
- Standard fixed-needle insulin syringes and safety insulin syringes require separate catalog records and workplace-use evaluation.
- Build the final stocking mix from the pharmacy’s own 90-day and 12-month exact-SKU movement, lead-time and substitution records.
- Compare bulk insulin syringe quotes only after normalizing the exact SKU, package hierarchy, remaining shelf life and landed cost.
1. What “Common” Means in This Insulin Syringe Specifications Guide
Search results often answer “what are the common insulin syringe sizes?” with three capacities and then move directly into patient education. Product pages take the opposite approach: they list an individual SKU, but rarely show a pharmacy how to build an assortment. The useful middle ground is a procurement matrix based on configurations that recur across current U.S.-market manufacturer and distributor portfolios.
FDA’s public summary for one currently cleared insulin syringe family, for example, describes 0.3 mL, 0.5 mL and 1 mL volumes, 28G through 32G needles, and 6 mm, 8 mm and 12 mm lengths. That establishes a broad available product family; it does not prove how much of each REF U.S. pharmacies sell.[1] Current embecta, EasyTouch, UltiCare and Medline portfolios provide additional evidence that several short- and traditional-length combinations remain commercially listed.[2] [3] [4] [5]
Evidence boundary
In this article, common means repeatedly listed in current U.S.-market portfolios. It does not mean every pharmacy should stock every configuration, or that the sequence below represents national market share.
2. U.S. Pharmacy Insulin Syringe Specification Matrix
The following insulin syringe size chart is a candidate-assortment tool. It helps a buyer decide which exact products need commercial and clinical review; it is not an instruction to substitute a product or select a device for an individual.
| Capacity category | Representative listed needle patterns | Graduation control | Pharmacy purchasing use |
|---|---|---|---|
| 0.3 mL / 3/10 cc | Selected 31G × 6 mm and 31G × 8 mm configurations; other combinations vary by portfolio | Half-unit and one-unit patterns may exist; confirm the exact REF and barrel artwork | Separate fine-graduation requirements from general 0.3 mL stock |
| 0.5 mL / 1/2 cc | Selected 31G short-needle and 29G/30G traditional-length configurations | Do not infer the increment from 50-unit maximum capacity | Maintain an exact mid-capacity SKU rather than an open “equivalent” item |
| 1 mL / 1 cc | Selected 31G × 6/8 mm and 29G/30G × approximately 12–12.7 mm configurations | Verify the printed unit increment and maximum marking by REF | Consider separate controlled records for short- and traditional-length items |
| Safety insulin syringe | Capacity, gauge and length depend on the safety design and manufacturer | Verify both the measurement scale and activation mechanism | Evaluate separately for employee-use workflows and sharps exposure controls |
The matrix should be read row by row, not as a list of universal combinations. For current Tonmit options, buyers can review wholesale insulin syringe configurations and then request the exact REF, scale, graduation and package record for the item under consideration.
3. Common Barrel Capacities: 0.3 mL, 0.5 mL and 1 mL
Capacity describes nominal barrel volume. The common U.S. catalog categories are 0.3 mL, 0.5 mL and 1 mL; they may also appear as 3/10 cc, 1/2 cc and 1 cc. One cubic centimeter equals one milliliter, so the two notations describe the same nominal volume. Capacity does not establish the insulin concentration scale or the graduation interval.
| Nominal capacity | Equivalent notation | Maximum marking when correctly scaled for U-100 | Required buyer verification |
|---|---|---|---|
| 0.3 mL | 0.3 cc / 3/10 cc | 30 units | Scale, half- or one-unit graduation, gauge, length, REF and pack |
| 0.5 mL | 0.5 cc / 1/2 cc | 50 units | Scale, graduation, gauge, length, REF and sterile package |
| 1 mL | 1 cc | 100 units | Scale, graduation, needle, identifiers, box and case hierarchy |
Buyers who need the clinical and measurement distinctions can compare 0.3 mL, 0.5 mL and 1 mL insulin syringe sizes. For commercial review, use the dedicated 0.3 mL insulin syringe options, 0.5 mL insulin syringe options and 1 mL insulin syringe options as starting points, then confirm the final quoted SKU.
4. Insulin Syringe Gauge Sizes and Needle-Length Combinations
Needle gauge and needle length are independent fields. A higher gauge number generally describes a smaller outside needle diameter, so 31G is generally thinner than 30G, and 30G is generally thinner than 29G. Length is recorded separately in millimeters and, where used, inches. Neither field identifies the insulin scale, barrel capacity or graduation.
Current portfolios demonstrate why a search such as “31G 8mm insulin syringe” is still incomplete. UltiCare lists both 0.3 mL and 1 mL U-100 products at 31G × 8 mm, while other lines list 29G × 12.7 mm. The same needle description can therefore belong to multiple capacities and product identities.[4]
Do not approve by gauge alone
“31 gauge insulin syringe” is a search phrase, not a complete purchase description. Pair it with scale, capacity, graduation, length, design, manufacturer REF and package hierarchy before comparing price.
5. Graduation Patterns and Half-Unit Insulin Syringes
Graduation is the interval represented by the smallest printed scale division. It controls how the barrel is read, but it cannot be safely inferred from capacity. Selected smaller-capacity products may provide half-unit markings, while other products of the same nominal volume may use a different pattern. A buyer should review the controlled specification, current labeling and a clear sample of the actual barrel.
Product photography and AI-generated imagery are not primary evidence for graduation approval. Perspective, resolution and synthetic markings can make a scale appear different from the manufactured product. Keep the approved scale drawing or label revision with the item-master record and require re-review when the REF or packaging revision changes.
Procurement rule: “0.3 mL insulin syringe” does not automatically mean “half-unit insulin syringe.” Graduation belongs in the RFQ, purchase order and receiving specification as its own controlled field.
6. How to Decode a Complete Pharmacy Insulin Syringe SKU
A complete description should progress from the highest-risk identity fields to the commercial package. The sequence below can be copied into an item master, RFQ or approved-product list.
U-100 scale | 0.5 mL / 50-unit maximum | exact graduation interval |
31G × 8 mm fixed needle | sterile, single use | individual sterile
barrier | 10/bag where applicable | 100/box | exact boxes/case |
legal manufacturer | labeler/brand | manufacturer REF | UDI/GTIN where
applicable | lot and expiration format | approved label revision
The example is a data structure, not a universal Tonmit or industry pack. If the quoted product does not use an inner bag, or if the box quantity is not 100, the record should reflect the actual configuration. Keep U-40 and U-100 identities separate and review the U-40 and U-100 syringe differences before approving either scale.
7. Build Core Stock, Secondary Stock and Special-Order Tiers
A practical assortment does not require every published configuration to sit in every pharmacy. Assign each approved REF to a stocking tier based on exact-SKU movement, clinical and dispensing requirements, supply lead time and the operational cost of a stockout.
| Tier | Definition | Typical control | Review trigger |
|---|---|---|---|
| Core stock | Exact SKUs with sustained local or network demand | Routine min/max or reorder-point replenishment | Monthly service level, fill rate and expiry risk |
| Secondary stock | Approved SKUs with stable but lower movement | Lower safety stock or hub-and-spoke availability | Quarterly demand and transfer frequency |
| Special order | Half-unit, safety, traditional-length or other narrow-demand REF | Order against confirmed requirement | Lead-time failure or repeated emergency demand |
| Non-substitutable | Different scale, graduation or other clinically controlled identity | Hard substitution block unless formally approved | Formulary, label, supplier or product change |
8. Standard Fixed-Needle vs Safety Insulin Syringes
A standard fixed-needle syringe should not be described as a safety syringe unless it has a documented engineered sharps-injury protection feature. Safety products require their own evaluation of the protective mechanism, activation, training, disposal workflow and product identity.
OSHA defines engineering controls to include sharps disposal containers, self-sheathing needles and safer medical devices that isolate or remove the workplace hazard. Employers with occupational exposure must evaluate and implement appropriate effective controls, but this does not mean that every retail insulin syringe SKU is automatically a safety device.[8]
9. Why the Same Capacity and Gauge Do Not Prove Interchangeability
Two items labeled 0.5 mL and 31G can still differ in insulin scale, graduation, needle length, fixed-needle geometry, sterile presentation, package quantity, labeling, identifiers and safety design. Treat a proposed replacement as a controlled product change, not a text-match exercise.
- Confirm the same approved insulin concentration scale.
- Compare nominal capacity, maximum unit marking and graduation.
- Compare gauge, needle length and device configuration.
- Reconcile legal manufacturer, labeler, REF and current labeling.
- Review sterile barrier, box/case quantities and shelf-life terms.
- Verify applicable documentation and change-notification requirements.
- Record the formal approval before enabling a catalog substitution.
10. REF, UDI/GTIN and Wholesaler Numbers in the Pharmacy Item Master
A pharmacy may encounter several identifiers for the same commercial product. They serve different systems and should not be collapsed into a single unlabeled number. FDA explains that the UDI system is intended to identify medical devices through manufacturing, distribution and use; the applicable device identifier should remain connected to the specific model or version and labeler.[6]
| Field | Purpose | Control question |
|---|---|---|
| Legal manufacturer / labeler | Regulatory and commercial identity | Which organization applies to this exact label? |
| Manufacturer REF | Primary SKU-level specification link | Does the PO prohibit unapproved equivalent substitution? |
| UDI/GTIN where applicable | Device and package identification | Which package level and version does the identifier represent? |
| Wholesaler order number | Channel-specific ordering | Is it mapped to the same current manufacturer REF? |
| Lot / expiration | Traceability, rotation and field-action response | Can receiving and downstream distribution retain the link? |
| Label/package revision | Change control | Has the approved product presentation changed? |
Registration and listing should also be interpreted accurately. FDA states that it does not issue registration certificates to medical-device facilities, and registration or listing does not by itself mean that the facility or device is approved, cleared or authorized.[7] Buyers can request SKU-specific product documentation and reconcile it with the quoted REF and current label.
FDA’s Quality Management System Regulation became effective on February 2, 2026 and incorporates ISO 13485:2016 by reference with additional applicable U.S. requirements. For procurement teams, the practical question remains whether the exact product, site and controlled records support the quoted configuration—not whether a sales document uses a broad quality claim.[9]
11. Are Insulin Syringes Always 100 per Box?
One hundred syringes per box is a familiar current presentation, and individual UltiCare listings show a quantity of 100. It is not safe to convert that observation into a universal rule for every manufacturer, sterile presentation, safety design or case pack.[4] The RFQ and purchase order should state each level explicitly.
Total syringes per case = syringes per box × boxes per case
Landed cost per accepted 100 = total landed case cost ÷ accepted syringes per case × 100
Usable supply = received quantity that passes identity, package-integrity, lot and shelf-life acceptance
Compare inner-pack format, units per box, boxes per case, total case quantity, freight basis, minimum remaining shelf life and damage/shortage terms. The separate guide explains how to compare insulin syringe case quantities and landed cost without treating case price as the only decision field.
12. Determine the Stocking Mix From Pharmacy Movement Data
A public common-specification matrix supplies candidates. The pharmacy’s own data determines quantities. Export movement by exact REF—not by a generic “insulin syringe” category—so that different graduations, capacities and needle configurations are not blended into one demand line.
- 90-day and 12-month unit movement by exact REF and location;
- average demand, variability and seasonal or promotion effects;
- available inventory, open purchase orders and backorders;
- effective replenishment lead time, including review and processing;
- service-level target, safety stock and stockout consequence;
- minimum acceptable remaining shelf life and expiration exposure;
- emergency transfers, lost sales and approved-substitution history;
- new-contract, formulary or prescriber-demand changes.
Basic reorder point = expected demand during effective replenishment lead time + safety stock
Recalculate inputs by exact SKU. A U.S. warehouse can reduce parts of lead time, but available quantity, reservation status, shelf life, cutoff time and destination-specific delivery still require order-level confirmation.
For recurring programs, confirm U.S.-warehouse-supported fulfillment by REF, available inventory, lot, expiration, processing window and delivery destination before reducing local safety stock.
13. Receiving and Replenishment Checklist
A controlled specification only works if receiving verifies the same fields. Connect the purchase order, packing list, physical package and inventory record before releasing stock.
Brand, manufacturer, REF and scale.
Capacity, graduation, gauge, length and design.
Units, boxes, cases and shortages.
Lot, expiration and package revision.
Accept, quarantine and document discrepancies.
If a label, REF, scale or package hierarchy differs from the approved record, place the affected stock on hold until the change is reconciled. Do not fix a mismatch by editing the internal description to match what arrived; determine whether the shipment or the approved record is wrong.
14. Copyable Pharmacy Insulin Syringe RFQ Specification
The following template is designed for pharmacy groups, clinics and distributors requesting wholesale or bulk insulin syringes. Replace every bracketed field and keep “no substitution without written approval” in the commercial terms where appropriate.
Product: Insulin syringe, sterile, single use
Concentration scale: [U-40 or U-100; exact requirement]
Capacity: [0.3 mL / 0.5 mL / 1 mL]
Maximum marking and graduation: [exact unit maximum] / [exact smallest increment]
Needle: [gauge] × [length in mm and inches], [fixed needle or approved safety design]
Primary presentation: [individual sterile barrier; inner-bag structure if applicable]
Commercial pack: [units/box] × [boxes/case] = [total units/case]
Identity: [legal manufacturer] / [labeler or brand] / [manufacturer REF] / [UDI or GTIN where applicable]
Documentation: Current specification, label/IFU, applicable regulatory and quality records, sterility and shelf-life information
Acceptance: Minimum remaining shelf life [__ months]; assigned lot and expiration confirmed before shipment
Volume: Trial [__ cases]; monthly [__ cases]; annual forecast [__ cases]
Delivery: Destination ZIP [_____]; requested date [_____]; U.S. stock or production route identified
Substitution: No manufacturer, REF, scale, graduation, needle, package or label change without prior written approval
This level of detail also makes high-intent questions such as “insulin syringes 100 per box,” “buy insulin syringes by the case” and “pharmacy insulin syringe supplier” commercially answerable without sacrificing specification accuracy.
Frequently Asked Questions About Insulin Syringe Specifications
What insulin syringe specifications are commonly listed in U.S. pharmacy catalogs?
Recurring capacity categories are 0.3 mL, 0.5 mL and 1 mL. Current portfolios also list several 29G, 30G and 31G fixed-needle products, including selected 6 mm, 8 mm and approximately 12–12.7 mm lengths. Exact combinations vary by manufacturer and REF.
Are 0.3 mL, 0.5 mL and 1 mL the standard insulin syringe sizes?
They are the recurring nominal capacity categories in current U.S. product families. Capacity alone does not identify concentration scale, graduation, gauge, length, brand or package.
Is 1 cc the same as 1 mL?
Yes. One cubic centimeter equals one milliliter, so 1 cc and 1 mL describe the same nominal volume. Insulin units are a separate field tied to the labeled concentration and matching syringe scale.
Which is thinner, a 30G or 31G insulin syringe needle?
A 31G needle generally has a smaller outside diameter than a 30G needle. Gauge does not establish needle length, capacity, scale or the correct product for an individual.
Do all 0.3 mL insulin syringes have half-unit markings?
No. Selected 0.3 mL SKUs may offer half-unit markings, but capacity does not prove graduation. Verify the exact REF, controlled scale drawing and current product labeling.
Can two insulin syringes with the same capacity and gauge be substituted?
Not automatically. They may differ in concentration scale, graduation, length, design, manufacturer, labeling, sterile barrier, package quantity and regulatory identity. Follow the organization’s formal product-review and substitution process.
Are insulin syringes always sold 100 per box?
No universal package quantity should be assumed. One hundred per box is a familiar presentation, but the actual inner pack, box and case hierarchy must be confirmed for the quoted SKU.
How should a pharmacy determine which insulin syringe SKUs to stock?
Start with approved candidate specifications, then use 90-day and 12-month movement by exact REF, lead time, demand variability, service targets, shelf life and stockout consequences to assign core, secondary and special-order tiers.
15. Conclusion: Stock a Controlled SKU, Not a Generic Size
The most useful answer to “common insulin syringe specifications used by U.S. pharmacies” is not a single winning size. It is a controlled set of recurring capacity and needle categories, translated into exact SKUs and then weighted by the pharmacy’s own demand.
Use 0.3 mL, 0.5 mL and 1 mL as capacity candidates; treat 29G, 30G and 31G plus the listed needle lengths as separate specification fields; verify graduation and concentration scale by REF; distinguish standard and safety designs; preserve manufacturer, identifiers, package revision, lot and expiration; and prohibit unapproved substitutions. That process turns a high-traffic size question into an item master, stocking plan, purchase order and receiving control that a pharmacy can actually use.
Wholesale & specification support
Request a Pharmacy Insulin Syringe SKU Review
Send Tonmit your required scale, capacity, graduation, gauge × length, monthly or annual volume, box/case needs, destination ZIP code and documentation requirements. We can organize the requested fields into a comparable specification and confirm transaction-specific options.
Availability, documentation, packaging, inventory, remaining shelf life, price and delivery are confirmed for the exact SKU and transaction.References
- U.S. Food and Drug Administration. “510(k) Summary, K223453 — Insulin Syringe.” Current FDA database record and summary reviewed August 7, 2026. View FDA 510(k) summary.
- embecta. “Healthcare Providers — Insulin Syringes.” Current U.S. product-family information reviewed August 7, 2026. View embecta portfolio.
- MHC Medical Products. “EasyTouch U-100 Syringes.” Current gauge and product-family information reviewed August 7, 2026. View EasyTouch product family.
- UltiMed. “UltiCare U-100 Insulin Syringes.” Current product-family and selected 0.3 mL, 0.5 mL and 1 mL ordering pages reviewed August 7, 2026. View UltiCare product family.
- Medline. “Standard Insulin Syringes with Fixed Needle.” Current capacity, gauge and needle-length catalog fields reviewed August 7, 2026. View Medline product family.
- U.S. Food and Drug Administration. “UDI Basics.” Reviewed August 7, 2026. View FDA UDI guidance.
- U.S. Food and Drug Administration. “Important Reminders About Registration and Listing.” Reviewed August 7, 2026. View FDA registration and listing reminder.
- Occupational Safety and Health Administration. “Quick Reference Guide to the Bloodborne Pathogens Standard.” Reviewed August 7, 2026. View OSHA guidance.
- U.S. Food and Drug Administration. “Quality Management System Regulation (QMSR).” Effective February 2, 2026; reviewed August 7, 2026. View FDA QMSR resource.
